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Metabolic adaptation is required to cope with
episodes of protein deprivation and malnutri-
tion. GCN2 eIF2a kinase, a sensor of amino
acid deficiency, plays a key role in yeast and
mammals inmodulating amino acidmetabolism
aspart of adaptation tonutrient deprivation. The
role of GCN2 in adaptation to long-term amino
aciddeprivation inmammals, however, is poorly
understood. We found that expression of lipo-
genic genes and the activity of fatty acid syn-
thase (FAS) in the liver are repressed and lipid
stores in adipose tissue are mobilized in wild-
type mice upon leucine deprivation. In contrast,
GCN2-deficient mice developed liver steatosis
and exhibited reduced lipid mobilization. Liver
steatosis in Gcn2/ mice was found to be
caused by unrepressed expression of lipogenic
genes, including Srebp-1c and Fas. Thus, our
study identifies a novel function of GCN2 in
regulating lipid metabolism during leucine dep-
rivation in addition to regulating amino acid
metabolism.
INTRODUCTION
Organisms have evolved a repertoire of adaptations to
cope with episodes of malnutrition and starvation. To
maintain vital functionsduringprolongedmalnutrition, pro-
teins, carbohydrates, lipids, and other biomolecules are
mobilized from skeletal muscle, adipose tissues, and spe-
cific internal organs including the liver (Anthonyet al., 2004;
Heard et al., 1977;Munro, 1975). Amino acid deprivation in
mammals is particularly problematic as nine amino acids
cannot be synthesized de novo; consequently, some pro-
teins must be degraded to redeploy essential amino acids
for synthesis of proteins vital for survival. Recycling of
nonessential proteins in skeletal muscle and some internal
organs such as liver results in overall reduction in body
weight (Adibi, 1976; Kerr et al., 1978).
Adaptive changes to amino acid deprivation have been
extensively studied in yeast, where they have been shown
to be regulated by the general control nonderepressibleCell M2 (GCN2) kinase, which is activated by uncharged tRNA-
dependent mechanisms (Hinnebusch, 1994; Wek et al.,
1995). Activated GCN2 kinase phosphorylates eukaryotic
initiation factor 2a (eIF2a) and results in derepression of
the translation of the transcription factor GCN4. Elevated
levels of GCN4 stimulate the expression of hundreds of
genes, including enzymes required to synthesize all 20
major amino acids (Hinnebusch, 1997; Mueller and Hinne-
busch, 1986).
The response to amino acid deprivation in mammals is
characterized by repression of protein synthesis and up-
regulation of amino acid biosynthesis and transporters
(Anthony et al., 2004; Averous et al., 2003; Kilberg et al.,
2005). GCN2 is thought to play a dual role in mammals
by upregulating the synthesis of nonessential amino acids
and regulating a complex array of adaptation to cope with
the loss of essential amino acids (Anthony et al., 2004; Ber-
langa et al., 1999; Maurin et al., 2005; Sood et al., 2000;
Zhang et al., 2002b). Rodents exhibit an aversive behavior
toward fooddeficient in essential aminoacids,which is lost
inGcn2mutant mice (Hao et al., 2005; Maurin et al., 2005).
Fetal development is also impaired in Gcn2/ mice if
dietary essential amino acids are lacking during gestation
(Zhang et al., 2002b).
As essential amino acid limitation in nature is almost al-
ways correlated with nutrient deprivation or starvation, we
speculated that GCN2 may act as a master regulator of
metabolic adaptation to nutrient deprivation. The potential
coordinate regulation of diverse metabolic pathways dur-
ing essential amino acid deprivation was suggested by
a recent study in cultured hepatocyte-derived HepG2 cells
showing that, when any of the essential amino acids is
absent, expressionof fatty acid synthase (FAS), a keycom-
ponent of lipid synthesis, is downregulated (Dudek and
Semenkovich, 1995). Inasmuch as lipid synthesis and
adaptation to essential amino acid deprivation are bio-
chemically distinct, we speculated that this response re-
flects an underlying mechanism modulating multiple met-
abolic pathways in response to nutrient deprivation. As
deficiency of amino acid is sensed by GCN2, we hypothe-
sized that GCN2 might be involved in repressing lipid
synthesis during amino acid deprivation. To investigate
this hypothesis, we examined the response of Gcn2+/+
and Gcn2/ mice to deprivation of the essential amino
acid leucine. We found that lipid synthesis was repressed
in the livers of Gcn2+/+ mice during prolonged leucineetabolism 5, 103–114, February 2007 ª2007 Elsevier Inc. 103
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GCN2 Regulates Lipid MetabolismTable 1. Phenotypic Differences between Wild-Type (+/+) and Gcn2 Knockout (/) Mice on Control and
Leucine-Deficient Diet
+/+ /
Parameter Control Diet ()leu Diet Control Diet ()leu Diet
17 Days
Food intake reduction (%) 1.7 ± 3.1 32.0 ± 3.8* 1.8 ± 6.0 34.4 ± 4.2*
Body weight reduction (%) 6.7 ± 1.6 28.6 ± 1.0* 5.4 ± 2.0 27.4 ± 2.2*
Liver weight (mg) 1092.8 ± 37.8 569.4 ± 31.6* 1135.0 ± 73.1 966.0 ± 54.6
Liver weight/body weight (%) 4.5 ± 0.1 3.7 ± 0.2* 4.1 ± 0.3 5.6 ± 0.1*
Adipose tissue weight (mg) 854.4 ± 138.1 25.4 ± 10.4* 745.4 ± 125.1 231.8 ± 25.3*
Adipose tissue weight/body weight (%) 3.5 ± 0.6 0.2 ± 0.1* 2.8 ± 0.5 1.3 ± 0.1*
7 Days
Food intake reduction (%) 2.6 ± 3.0 21.8 ± 4.7* 2.2 ± 4.2 21.2 ± 5.1*
Body weight reduction (%) 2.5 ± 1.5 11.8 ± 1.0* 2.1 ± 2.2 10.0 ± 1.6*
Liver weight (mg) 948.0 ± 65.9 911.0 ± 74.8 1059.0 ± 64.0 1247.0 ± 49.9*
Liver weight/body weight (%) 4.4 ± 0.1 4.3 ± 0.3 4.4 ± 0.1 5.2 ± 0.3*
Adipose tissue weight (mg) 461.0 ± 104.8 234.0 ± 47.7 562.0 ± 66.3 468.0 ± 50.4
Adipose tissue weight/body weight (%) 2.1 ± 0.3 1.1 ± 0.2* 2.2 ± 0.2 1.9 ± 0.2
Liver cholesterol content (mg/g) 59.5 ± 3.6 59.0 ± 1.5 58.2 ± 1.0 56.7 ± 1.9
Liver triglyceride content (mg/g) 54.8 ± 1.4 56.5 ± 2.2 54.3 ± 1.8 100.0 ± 1.8*
Liver glycogen content (mmol/mg) 148.0 ± 7.6 146.0 ± 4.0 151.0 ± 4.6 150.0 ± 9.8
Serum cholesterol (mg/dl) 138.9 ± 3.0 147.0 ± 6.8 138.0 ± 4.7 149.0 ± 8.3
Serum triglycerides (mg/dl) 54.3 ± 1.6 35.0 ± 1.5* 55.9 ± 1.4 25.6 ± 1.6*
Serum free fatty acid (mEq/l) 0.7 ± 0.0 0.4 ± 0.1* 0.7 ± 0.1 1.1 ± 0.1*
Serum insulin (ng/ml) 0.6 ± 0.1 0.2 ± 0.0* 0.7 ± 0.1 0.2 ± 0.0*
Blood glucose (mg/dl) 178.7 ± 10.0 168.4 ± 7.1 182.2 ± 7.0 169.5 ± 7.0
Fatty liver No No No Yes
Two- to three-month-old mice were maintained on either nutritionally complete amino acid diet (control diet) or diet devoid of
leucine (()leu diet) for 17 or 7 days. Numbers and sex ofmice used: for 17 days, n = 5 (3male, 2 female) per treatment per genotype;
for 7 days, control diet: n = 6 (3 male, 3 female) per genotype, ()leu diet: n = 8 (5 male, 3 female) per genotype. Values represent
mean ± SEM. Total food intake refers to the total amount of control or leucine-deficient diet consumed during 17 or 7 days. *p < 0.01
by two-tailed Student’s t test for effect of ()leu diet versus control diet within the same strains of mice. For all parameters
examined, no significant difference was observed between the two Gcn2 strains fed control diet or between genders in response
to ()leu diet.deprivation,whereas lipid synthesis continuedunabated in
Gcn2/mice, resulting in severe liver steatosis. Failure to
downregulate lipid synthesis was found to be due to per-
sistent expression of sterol regulatory element-binding
protein 1c (SREBP-1c) and its downstream transcriptional
targets underlying fatty-acid and triglyceride synthesis.
RESULTS
Leucine Deprivation Results in Radical Changes
in Liver and Adipose Tissue Mass
A pilot experiment was conducted to assess the effect of
leucine deprivation inmice asa function ofGcn2genotype.
Gcn2+/+ and Gcn2/ mice were maintained on either
a control diet or a diet lacking leucine for 17 days. Leucine104 Cell Metabolism 5, 103–114, February 2007 ª2007 Elseviedeprivation resulted in a reduction in food intake and
body weight in both Gcn2+/+ and Gcn2/ mice (Table 1).
Gcn2+/+mice fed the leucine-deprived diet for 17 days ex-
perienced a 48% loss of liver mass and a dramatic 97%
loss of abdominal adipose mass, whereas Gcn2/ mice
showed no apparent loss of liver mass and much less
severe loss of adipose tissue (69% reduced) compared
to mice fed the control diet. A second leucine-deprivation
feeding experiment was conducted for a period of 7 days
to better assess the more immediate effects of leucine-
deprivation. Liver mass was similar in Gcn2+/+ mice fed
the leucine-deprived diet compared to the control diet
during this shorter period, whereas adipose tissue was
reduced by almost 50% (Table 1). In contrast, liver mass
was significantly increased in GCN2-deficient mice fedr Inc.
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GCN2 Regulates Lipid MetabolismFigure 1. Leucine-Deprived Gcn2/ Mice Exhibit Severe Liver Steatosis
Liver histology for wild-type (+/+) and Gcn2 KO (/) mice. Mice were fed either control diet or leucine-deficient diet for 7 days. Liver tissue
sections from control and ()leu diet group animals were stainedwith oil redO (A, 403magnification) or hematoxylin and eosin (B, 203magnification).
Lipid deposits are detected as red-stained areas in (A) and white empty areas in (B). Images shown are representative of several animals for
each group.the leucine-deprived diet compared to the control diet, but
no significant difference in adipose mass was seen.
Gcn2/ Mice Display Severe Liver Steatosis
When Fed a Leucine-Deprived Diet
The livers ofGcn2/mice fed a leucine-deficient diet for 7
daysappearedverypale, suggesting severe liver steatosis.
This observation was confirmed by histological examina-
tion of the liver, which revealed extensive lipid deposition
manifested as macro- and microvesicular steatosis (Fig-
ures 1A and 1B). Leucine deprivation had no effect on total
cholesterol in the liver in either strain of mice. By contrast,
leucine deprivation dramatically increased liver triglycer-
ides inGcn2/mice compared toGcn2+/+mice (Table 1).
As observed for liver, cholesterol in serumwasnot affected
by leucine deprivation in either Gcn2+/+ or Gcn2/ mice.
Leucine deprivation reduced triglyceride levels in serum
significantly in Gcn2+/+ mice and significantly more in
Gcn2/mice. Leucine deprivation resulted in significantly
decreased free fatty acids in serum in Gcn2+/+ mice; in
contrast, fatty-acid levels increased in serum in Gcn2/
mice. Taken together, these results suggest that leucine
deprivation rapidly results in liver steatosis caused by
deposition of triglycerides in the Gcn2/ mice. Leucine
deprivation resulted in decreased insulin levels in both ge-
notypes perhaps in part due to decreased food intake, but
serum glucose was unaffected by this diet (Table 1). Liver
glycogen content was equivalent across both diets and
genotypes (Table 1). Both strains of mice showed a normalCell Mglucose clearance when challenged with glucose injection
(see Figure S1 in the Supplemental Data available with this
article online).
Genes Related to Triglyceride Synthesis Are Not
Repressed in Gcn2/ Mice Fed
a Leucine-Deprived Diet
The accumulation of hepatic triglycerides inGcn2/mice
fed a leucine-deprived diet is likely to reflect an imbalance
in hepatic triglyceride synthesis, b-oxidation, and/or up-
take and/or secretion of fatty acids. For this reason, we ex-
amined changes in levels of mRNA expression for proteins
related to each of these processes. We first investigated
whether genes underlying the synthesis of triglycerides
are differentially regulated in Gcn2+/+ and Gcn2/ mice
during leucine deprivation. These proteins included acetyl
CoA carboxylase 1 (ACC1) and FAS, which together cata-
lyze the rate-limiting step in production of palmitate 16:0;
stearoyl CoA desaturase (SCD), which catalyses the syn-
thesis of oleic acid (18:1, n-9); ATP-citrate lyase (ACL),
which catalyzes the conversion of citrate to CoA and
oxaloacetate; and glucose-6-phosphate dehydrogenase
(G6PD) and malic enzyme (ME), which generate NADPH
for synthesis of fatty acids (Horton and Shimomura,
1999). Levels of Fas mRNA and protein were greatly re-
duced in the livers of Gcn2+/+ mice fed a leucine-deficient
diet but were not reduced in Gcn2/ mice (Figures 2A
and 2B). Similarly, FAS enzyme activity was reduced
by 74% in the livers of Gcn2+/+mice but was increasedetabolism 5, 103–114, February 2007 ª2007 Elsevier Inc. 105
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GCN2 Regulates Lipid MetabolismFigure 2. Lipogenic Genes Are Not Repressed in Livers of Leucine-Deprived Gcn2/ Mice
Expression of lipogenic genes in the livers of Gcn2 KO (/) and wild-type (+/+) mice fed either control diet or leucine-deficient diet for 7 days. Data
are mean ± SEM of at least two independent real-time PCR experiments per animal (A) or western blot (B) with mice of each diet for each experiment
(WT: control diet [n = 6], ()leu diet [n = 8]; KO: control diet [n = 6], ()leu diet [n = 8]). *p < 0.0001 by two-tailed Student’s t test for effect of ()leu diet
versus control diet compared within the same strains of mice.
(A) Expression of Fas, Scd, Acl, G6pd, Me, and Acc1 mRNAs.
(B) FAS protein (top, western blot; bottom, FAS protein relative to tubulin and normalized to control diet group within same strain of mice).
(C) FAS enzyme activity.1.5-fold in Gcn2/ mice under leucine deprivation
(Figure 2C). Leucine deprivation also resulted in a large
decrease in the mRNA levels of Acl, Scd, G6pd, and Me
in the livers of Gcn2+/+ mice. In contrast, the expression
of these lipogenic genes was not repressed in the livers
of leucine-deprived Gcn2/ mice and, in the case of
ACL, G6PD, and ME, their mRNA expression was in-
creased (Figure 2A). The increase in G6PD and ME ex-
pression may enhance the production of NADPH, which
is required as the reducing power to drive fatty-acid syn-
thesis. Only Acc1 mRNA, among the fatty-acid synthesis
genes, was expressed at equivalent levels in mice fed
control or leucine-deficient diets in the livers of both
Gcn2+/+ and Gcn2/ mice (Figure 2A).
The expression of cholesterol synthesis genes including
3-hydroxy-3-methylglutaryl (HMG)-CoA synthase, HMG-
CoA reductase, and farnesyl diphosphate synthase was
unchanged in the livers of either Gcn2+/+ or Gcn2/
mice maintained on a leucine-deficient diet (data not
shown). These results are consistent with the observation
that leucine deprivation did not result in a significant
change in liver cholesterol levels in Gcn2+/+ or Gcn2/
mice (Table 1).106 Cell Metabolism 5, 103–114, February 2007 ª2007 ElsevierExpression of SREBP-1c and PPARg Is Repressed
in Wild-Type, but Not Gcn2/, Mice Fed
a Leucine-Deprived Diet
Lipogenic genes in the liver are regulated primarily by
SREBP-1c (Brown and Goldstein, 1997) and secondarily
by peroxisome proliferator-activated receptor g (PPARg)
(Herzig et al., 2003) and carbohydrate response element-
binding protein (ChREBP) (Dentin et al., 2006; Iizuka et al.,
2006). Expression of Srebp-1cmRNA in liver was reduced
43%by leucinedeprivation inGcn2+/+mice,whereas itwas
increased by 176% in Gcn2/mice (Figure 3A). Reduced
expression of Srebp-1c mRNA in Gcn2+/+ mice was ac-
companied by an 80% reduction in the precursor and
mature, nuclear-localized SREBP-1c protein, whereas it
was unchanged in the livers of Gcn2/ mice (Figures 3B
and3C). Incontrast, theexpressionofSREBP-1aprecursor
proteinwasnotaltered ineitherdietorgenotype (Figure3B).
Regulators of SREBP processing including SCAP, S1P,
and Insig1 and 2a (Goldstein et al., 2006) were examined.
Scap mRNA was reduced in the livers of Gcn2+/+ mice
and S1p mRNA was increased in the livers of Gcn2/
mice under leucine deprivation, while the other genes
remained unchanged in both strains of mice.Inc.
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GCN2 Regulates Lipid MetabolismFigure 3. GCN2-Dependent Regulation
of SREBP-1c and PPARg
Expression of lipogenic regulatory factors in
the livers of Gcn2 KO (/) and wild-type
(+/+) mice fed either control diet or leucine-
deficient diet for 7 days. Data are mean ± SEM
of at least two independent real-time PCR
experiments (A and D) or western blot (B, C,
and E) with mice of each diet for each experi-
ment (WT: control diet [n = 6]; ()leu diet
[n = 8]; KO: control diet [n = 6]; ()leu diet
[n = 8]). *p < 0.0001 by two-tailed Student’s
t test for effect of ()leu diet versus control
diet within the same strains of mice.
(A) Expression of Srebp-1c, Scap, S1p, Insig1,
and Insig2a mRNA.
(B) SREBP-1c precursor protein (top, western
blot; bottom, SREBP-1c protein relative to NS
protein and normalized to control diet group
within same strains of mice).
(C) SREBP-1c nuclear mature form of SREBP-
1c (top, western blot; bottom, SREBP-1c
protein relative to tubulin and normalized to
control diet group within same strain of mice).
(D) Expression of Pparg mRNA.
(E) PPARg protein from nuclear extraction (top,
western blot; bottom, PPARg protein relative
to tubulin and normalized to control group
within same strain of mice).Leucine deprivation had no significant effect on levels of
PpargmRNA in the livers ofGcn2+/+mice, but PPARg pro-
tein was moderately decreased (Figures 3D and 3E). Curi-
ously, Pparg mRNA was increased in the livers of leucine-
deprivedGcn2/mice,butPPARgproteinwasunchanged
(Figures 3D and 3E). Accumulation of fat could also be con-
trolled by ChREBP-stimulated glycolysis and lipogenesis
(Dentin et al., 2006; Iizuka et al., 2006). Glucose levels,
however, were unchanged in leucine-deprived Gcn2+/+
or Gcn2/ mice (Table 1). The expression of Chrebp and
its downstream target gene, liver pyruvate kinase (L-pk),
was also unchanged in the livers of both Gcn2+/+ and
Gcn2/mice under leucine deprivation (Figure S2).
b-Oxidation Genes Are Upregulated in Gcn2/Mice
Fed a Leucine-Deprived Diet
Impaired b-oxidation of fatty acids is another potential
cause of liver steatosis (Kersten et al., 1999; Leone et al.,
1999). To examine whether genes related to this process
are differentially regulated by leucine deprivation in
Gcn2+/+ and Gcn2/ mice, the expression level of
mRNAs encoding the transcription factor PPARa and itsCell Mtarget genes fatty acyl-CoA oxidase (ACO) and long-
and medium-chain acyl-CoA dehydrogenase (LCAD and
MCAD) were examined. Leucine deprivation had no effect
on levels of Ppara, Aco, Lcad, and Mcad mRNA in the
livers of Gcn2+/+ mice, whereas the expression of these
genes was markedly increased in Gcn2/ mice (Fig-
ure 4A). Thus, the expression of b-oxidation genes is not
impaired in Gcn2/ mice; rather, these genes are in-
duced, perhaps in response to increased fat accumulation
in the liver.
Fatty-Acid Transport Genes Are Upregulated
in Gcn2/ Mice Fed a Leucine-Deprived Diet
In addition to triglyceride synthesis and b-oxidation,
misregulation of triglyceride uptake and secretion could
also contribute to fatty liver (Bradbury, 2006).We therefore
examined genes related to the uptake of fatty acids, in-
cluding fatty acid binding protein (FABP), fatty acid trans-
locase (CD36), fatty acid transport protein (FATP), and
lipoprotein lipase (LPL) mRNAs. These genes were all
significantly increased in the livers of leucine-deprived
Gcn2/ mice, whereas Gcn2+/+ mice exhibited noetabolism 5, 103–114, February 2007 ª2007 Elsevier Inc. 107
Cell Metabolism
GCN2 Regulates Lipid MetabolismFigure 4. b-Oxidation and Fatty-Acid Transport Genes Are Upregulated in Livers of Gcn2/ Mice Fed a Leucine-Deficient Diet
Expression of b-oxidation and fatty-acid transport genes in the livers ofGcn2 KO (/) and wild-type (+/+) mice fed a leucine-deficient diet for 7 days
compared with control diet. Data are mean ± SEM of at least two independent real-time PCR experiments with mice of each diet for each experiment
(WT: control diet [n = 6]; ()leu diet [n = 8]; KO: control diet [n = 6]; ()leu diet [n = 8]). *p < 0.0001 by two-tailed Student’s t test for effect of ()leu diet
versus control diet within the same strains of mice.
(A) Ppara, Aco, Lcad, and Mcad mRNA.
(B) Fabp, cd36, Fatp, and Lpl mRNA.
(C) ApoB and ApoE mRNA.significant increase in the expression. Expression of ApoB
and ApoE mRNAs, which encode key proteins in lipid
secretion and transport, was also examined. ApoB mRNA
was increased in the livers of leucine-deprived Gcn2/
mice, but ApoE mRNA was unchanged in both strains
of mice (Figure 4B).
Leucine-Deprivation-Induced Liver Steatosis
in Gcn2/ Mice Is Prevented by Treatment
with C75, a Potent FAS Inhibitor
We postulated that failure to repress liver FAS expression
and induced FAS enzyme activity were major factors con-
tributing to persistent lipid synthesis and liver steatosis in
leucine-deprived Gcn2/ mice. To test this hypothesis,
we examined the ability of C75, a potent FAS inhibitor,
to repress lipid synthesis and the development of fatty
liver in leucine-deprived Gcn2/ mice. C75 has been
shown to inhibit FAS expression significantly in liver 24
hr after a single i.p. injection (Kim et al., 2002). We found
that liver steatosis was prevented in leucine-deprived
Gcn2/ mice that had received three doses of C75 over
the course of the 7 day period (Figure 5A). Moreover,
Fas mRNA and protein levels were repressed in the livers
of Gcn2/ mice (Figures 5B and 5C) to levels similar to108 Cell Metabolism 5, 103–114, February 2007 ª2007 Elsevierthose seen in leucine-deprived wild-type mice (Figures
2A and 2B). We also speculated that the activation of
Ppara mRNA and increased expression of b-oxidation
genes in the livers of leucine-deprived Gcn2/ mice
were secondary responses to increased triglycerides
and therefore should be ablated byC75 administration. In-
deed, the levels of Ppara and Aco mRNA in the livers of
leucine-deprived Gcn2/ mice were reduced by C75
treatment (Figures 5D and 5E).
Phosphorylation of eIF2a and Regulation of Amino
Acid Biosynthetic Genes Are GCN2 Dependent
in the Liver under Leucine Deprivation
Short-term leucine deprivation in cultured mouse embry-
onic fibroblasts was previously shown to result in potent
activation of GCN2 and phosphorylation of eIF2a (Harding
et al., 2003; Zhang et al., 2002b). In response, ATF4 is
induced translationally in cultured cells and activates the
expression of C/EBPb (Chen et al., 2005) and amino acid
metabolism and transport genes including asparagine
synthetase (Asns) (Harding et al., 2003; Siu et al., 2002).
However the GCN2 dependence of ASNS regulation
had not been tested in a whole animal system. We found
that the phosphorylated state of eIF2a in the livers wasInc.
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GCN2 Regulates Lipid MetabolismFigure 5. Leucine-Deprivation-Induced
Liver Steatosis in Gcn2/ Mice Is Pre-
vented by Inhibition of FAS Expression
Gcn2 KO (/) mice were fed a leucine-defi-
cient diet for 7 days and were given C75 at
a dose of 20 mg/kg body weight in 200 ml
RPMI or only RPMI every other day by i.p.
injection during this period. Error bars in
(B)–(E) = SEM.
(A) Liver histology for Gcn2 KO mice. Sections
from animals were stained with oil red O (403
magnification). Lipid deposits are detected as
red-stained areas.
(B and C) Expression of FasmRNA (B) and FAS
protein (C) (top, western blot; bottom, FAS
protein relative to tubulin and normalized to
control diet group within same strain of mice).
*p < 0.0001 by two-tailed Student’s t test for
effect of C75 treatment on Gcn2 KO mice fed
()leu diet versus no C75 treatment on Gcn2
KO mice fed ()leu diet or versus Gcn2 KO
mice fed control diet. Control diet (n = 6);
()leu diet (n = 5); ()leu diet + C75 (n = 3).
(D and E) Expression of Ppara and AcomRNA.
*a: p < 0.001 by two-tailed Student’s t test for
effect of C75 treatment versus no C75 treat-
ment on Gcn2 KO mice fed ()leu diet. *b:
p < 0.001 by two-tailed Student’s t test for
effect of ()leu diet versus control diet. Control
diet (n = 6); ()leu diet (n = 5); ()leu diet + C75
(n = 3).markedly increased in wild-type mice consuming a
leucine-deficient diet for 7 days compared to mice fed
a complete diet, whereas Gcn2/ mice lacked this in-
duction (Figure 6A). Asns and C/ebpb mRNAs were ex-
pressed at low levels in the livers of both strains of mice
when fed a complete diet (Figure 6B and 6C). The expres-
sion of these mRNAs, as well as the C/EBPb protein,
was induced markedly in the livers of leucine-deprived
Gcn2+/+ mice (Figures 6B–6D). In contrast, Asns mRNA
and C/ebpb mRNA and protein were not induced by the
leucine-deprived diet in the livers of Gcn2/ mice (Fig-
ures 6B–6D). To determine whether ATF4 was responsible
for the GCN2-dependent regulation of lipogenesis and
Asns mRNA expression, Atf4/ mice were subjected to
a leucine-deprived diet for 7 days. Unlike Gcn2/ mice,
Atf4/ mice did not develop fatty liver under leucine
deprivation, and liver Fas mRNA was repressed to an
extent similar to in Atf4+/+ mice (Figure S3). However,
Asns mRNA was not induced in the livers of leucine-
deprived Atf4/ mice (Figure S3), indicating that leu-
cine-deprivation-induced Asns mRNA expression is de-
pendent upon both GCN2 and ATF4 as was previouslyCell Mshown for cultured cells (Harding et al., 2003; Siu et al.,
2002).
DISCUSSION
During episodes of extended fasting, lipid synthesis in the
liver is downregulated and lipolysis in adipose tissue is
upregulated in concert with an overall shift in the balance
of anabolic and catabolic metabolism (Finn and Dice,
2006). Considering the known metabolic pathways of
amino acid and lipid metabolism, it could not have been
anticipated that deprivation of a single essential amino
acidwould impact lipidmetabolism. Yetwe found that lipid
synthesis is downregulated in the liver and adipose tissue
mass is reduced in wild-type mice fed a leucine-deficient
diet for several days. Based upon the unexpected findings
of this study, we propose that limitation of even a single
essential amino acid triggers a global nutrient-deprivation
response that includes the modulation of lipid synthesis.
As essential amino acid limitation in nature occurs during
general nutrient deprivation, we speculate that detection
of essential amino acid limitation acts to mobilize a globaletabolism 5, 103–114, February 2007 ª2007 Elsevier Inc. 109
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GCN2 Regulates Lipid MetabolismFigure 6. Phosphorylation of eIF2a and Regulation of Amino Acid Biosynthetic Genes Are GCN2 Dependent in the Liver under
Leucine Deprivation
Gcn2 KO (/) and wild-typemice (+/+) were fed control diet or leucine-deficient diet for 7 days. *p < 0.0001 by two-tailed Student’s t test for effect of
()leu diet versus control diet within the same strains ofmice. (WT: control diet [n = 6]; ()leu diet [n = 8]; KO: control diet [n = 6]; ()leu diet [n = 8].) Error
bars in (A)–(D) = SEM.




(D) C/EBPb protein from nuclear extraction (top, western blot; bottom, C/EBPb protein relative to tubulin and normalized to control diet group within
same strain of mice).
(E) Model of GCN2-dependent regulation of lipid metabolism in liver. Leucine deprivation results in activation of GCN2 and phosphorylation of eIF2a.
This is followed by repression of SREBP-1c and its downstream lipogenic genes and, in parallel, activation of ATF4 and C/EBPb, as well as their
downstream amino acid regulatory genes.adaptive metabolic response. The critical role of GCN2 in
regulating lipid metabolismwas shown by the rapid devel-
opment of liver steatosis in Gcn2/ mice during leucine
deprivation. Following a switch from a complete diet to a
leucine-deficient diet,Gcn2+/+mice downregulatemRNAs
encoding proteins linked to the synthesis of fatty acids and
triglycerides including SREBP-1c, ACL, FAS, SCD, G6PD,
and ME. These results are consistent with an in vitro study
showing that Fas mRNA expression is repressed by leu-
cine deprivation in HepG2 cells (Dudek and Semenkovich,
1995). In contrast, Gcn2/ mice fail to downregulate
these mRNAs, and some are even induced. Consistent
with changes in its gene and protein expression, FAS
enzyme activity is suppressed significantly by leucine
deprivation in the livers of Gcn2+/+ mice but is increased
1.5-fold in Gcn2/ mice. The importance of GCN2-
dependent repression of FAS was further demonstrated110 Cell Metabolism 5, 103–114, February 2007 ª2007 Elsevierby the ability of a potent FAS inhibitor to prevent liver
steatosis in leucine-deprived Gcn2/ mice. Increased
fat accumulation in liver could also arise from other
sources, including mobilization of free fatty acids from ad-
ipose tissue and increased dietary intake (Fong et al.,
2000). However, leucine-deprived Gcn2/ mice have
a higher percentage of adipose tissue relative to body
weight and consume less food compared to mice fed
a control diet. Thus, failure to repress lipogenesis is likely
to be the major cause of liver steatosis in these mice. We
speculate that our studies on leucine-deprived mice can
be extended to a deficiency of any of the essential amino
acids, inasmuch as Dudek and Semenkovich (1995)
showed that omission of any of the nine essential amino
acids from growth medium resulted in the repression of
FasmRNA and protein in HepG2 cells, whereas depriving
these cells of nonessential amino acids had no effect.Inc.
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GCN2 Regulates Lipid MetabolismThe decreased expression of lipogenic genes including
Fas, Acl, Scd,G6pd, andMe in response to leucine depri-
vationmay reflect repression of transcription, inasmuch as
these genes were previously shown to be regulated by the
transcription factor SREBP-1c as a function of nutritional
state (Horton and Shimomura, 1999). SREBP-1c belongs
toabasic helix-loop-helix/leucine-zipper transcription fac-
tor family, which also includes SREBP-1a and SREBP-2
(Brown and Goldstein, 1997). Among the SREBP family
of transcription factors, SREBP-1c preferentially regulates
genes involved in triglyceride and fatty-acid synthesis,
whereas SREBP-2 regulates genes related to cholesterol
synthesis. We found that mRNA and protein levels of
SREBP-1c are reduced by leucine deprivation in the liver
and that this effect is GCN2 dependent. The observation
that SREBP-1a protein levels do not change in response
to leucine deprivation suggests that SREBP-1c is the
isoform required to inhibit triglycerides in the liver during
leucine deprivation. No change in the expression of
SREBP-2 or its target genes was observed in the livers of
either strain of mice under leucine deprivation (unpub-
lished data). Triglyceride-enriched fatty liver, with no
increase in cholesterol, has been previously described in
transgenic mice that overexpress SREBP-1c in liver
(Shimano et al., 1997). PPARg, a secondary activator of
lipogenic gene expression in the liver (Herzig et al., 2003),
exhibits a modest reduction in the livers of leucine-
deprivedwild-typemice andmay therefore also contribute
to the reduction in triglyceride synthesis.
In addition to altered triglyceride synthesis, impairment
of b-oxidation and/or imbalance between triglyceride
uptake and secretion could also contribute to increased
accumulation of triglycerides in the livers of Gcn2/
mice. We showed that the transcription factor PPARa
and its target genes related to b-oxidation are significantly
upregulated in the livers of leucine-deprived Gcn2/
mice. The increased expression of b-oxidation genes,
however, is not sufficient to prevent the increased triglyc-
eride accumulation in the livers of Gcn2/ mice under
these conditions. We surmise that the increase of PPARa
and its downstream targets in b-oxidation is a secondary
response to the high level of triglyceride synthesis occur-
ring in leucine-deprived Gcn2/mice. In fact, it has been
shown that PPARa can be activated by fatty acids and
peroxisome proliferators (Chakravarthy et al., 2005; For-
man et al., 1997). This interpretation is also supported
by our finding that Ppara and Aco expression is repressed
by treatment with a FAS inhibitor.
In addition to its key role in regulating b-oxidation,
PPARa has been shown to positively regulate the expres-
sion of genes controlling fatty-acid uptake, including Lpl,
Fabp, cd36, and Fatp (Motojima et al., 1998; Tordjman
et al., 2001). We found that leucine deprivation results in
upregulation of these PPARa target genes facilitating
fatty-acid uptake into the liver. Thus, an increase in
fatty-acid uptake in leucine-deprived Gcn2/ mice is
likely a contributing factor to liver steatosis in these
animals. However, expression of ApoB, which functions
in the secretion of triglycerides from liver, was also up-Cell Mregulated by leucine deprivation, which would tend to
reduce fatty-acid accumulation. Moreover, we found
that further activation of PPARawith the agonist WY com-
pound in mice deprived of leucine was not able to prevent
the development of fatty liver in Gcn2/ mice (unpub-
lished data). Taken together, these results suggest that
increases in fatty-acid synthesis and uptake in the liver
outweigh apparent increases in b-oxidation and secretion
in Gcn2/ mice, resulting in fatty liver.
GCN2-dependent regulation of lipogenesis is likely to
entail regulation of SREBP-1c, as we found that the level
of Srebp-1c mRNA was substantially reduced in the liver
of wild-type mice, but not Gcn2 KO mice, fed a leucine-
deficient diet. The liver X nuclear transcription factor
a (LXRa), together with the retinoid receptor (RXR), is
a critical regulator of SREBP-1c transcriptional activation
(Chen et al., 2004; Liang et al., 2002) and therefore may
mediate GCN2-dependent regulation of SREBP-1c. Pre-
liminary studies have not shown a difference in the expres-
sion of LXRa in the liver between Gcn2 genotypes under
leucine deprivation (unpublished data). However, LXRa/
RXR transcriptional activity is regulated by oxysterols
and potentially other metabolites (Schultz et al., 2000),
which will require further study. The transcription factor
C/EBPb, which we found was GCN2-dependently in-
duced in the livers of leucine-deprived mice, may poten-
tially negatively regulate LXRa (Steffensen et al., 2002).
Previous studies have shown thatAsns gene expression
is potently activated in fibroblasts and hepatocytes upon
culturing in medium deprived of one or more essential
amino acids and that this induction is GCN2 and ATF4
dependent (Harding et al., 2003; Siu et al., 2002). C/EBPb
has also been found to be induced in cultured cells by
essential amino acid deprivation (Marten et al., 1994; Siu
et al., 2001), but its GCN2 dependence had not been
tested. In cell culture, high levels of phospho-eIF2a are
transient and limited by activation of phosphatase (Novoa
et al., 2001), raising the question of how long-term leucine
deprivation would impact GCN2 activation. Moreover, or-
ganisms are capable of reallocating essential amino acids
stored in various organs and tissues (Anthony et al., 2004),
and consequently, the effect of dietary leucine deprivation
on these pathways could not be assumed to be the same
in whole organisms subjected to prolonged leucine depri-
vation. Nonetheless, we found that the level of phospho-
eIF2a was indeed elevated by long-term leucine depriva-
tion and was GCN2 dependent. Moreover, Asns mRNA
and C/ebpb mRNA and protein were markedly induced
in the livers of leucine-deprived wild-type mice but not
GCN2-deficient mice. Both ATF4 and C/EBPb are critical
transcriptional regulators of the Asns gene, so one or both
of these factors may act directly or indirectly to repress
Srebp-1c transcription by leucine deprivation. Our results,
however, exclude ATF4 as a potential mediator of GCN2-
dependent regulation of lipogenesis, as leucine-deprived
Atf4/ mice did not develop fatty liver and Fas mRNA
was repressed similarly to in Atf4+/+ mice. However, we
did find that the GCN2-dependent regulation of Asns is
dependent upon ATF4.etabolism 5, 103–114, February 2007 ª2007 Elsevier Inc. 111
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GCN2 Regulates Lipid MetabolismNormally, mammals avoid eating food deficient in one
or more essential amino acids, and this behavior requires
the function of GCN2 in the central nervous system (Hao
et al., 2005; Maurin et al., 2005). This effect, however, is
a short-term response and is likely to be predicated
upon the availability of food choice. However, if animals
are not given a food choice over a longer period, aversive
behavior toward essential amino acid-deficient foods
would be maladaptive. Not surprisingly, then, we failed
to detect a difference between Gcn2+/+ and Gcn2/
mice in food intake during our several-day leucine-depri-
vation experiments. Instead, both genotypes continued
to consume food, but at a reduced rate. We speculate
that reduced food intake is likely due to an indirect meta-
bolic effect of leucine deficiency on appetite.
A previous study showed that liver mass is reduced in
mice fed a leucine-deprived diet (Anthony et al., 2004)
but did not investigate the impact on adipose tissue. We
were then surprised to observe an almost complete oblit-
eration of adipose tissue in leucine-deprived wild-type
mice after 17 days and a 50% reduction after only
a week. The adipose tissue of Gcn2/mice is somewhat
spared from this drastic reduction. We have not exten-
sively examined the cause of the reduction in adipose
tissue, but we speculate that it is due to enhanced lipoly-
sis, as other factors that influence adipose tissue mass
(e.g., lipogenesis, fatty-acid import, and cell death) do
not act so quickly to radically reduce adipose tissue.
Moreover, rapid reduction of adipose tissue during fasting
is known to be caused by increased lipolysis (Finn and
Dice, 2006), and our observation of repressed lipid synthe-
sis in the liver combined with reduction in adipose tissue is
characteristic of a fasting response.
In summary, our data suggest a novel function for
GCN2: downregulating genes related to triglyceride syn-
thesis and enzyme activity during leucine deprivation. By
regulating genes related to the synthesis of fatty acids,
GCN2 has a profound effect on the synthesis and storage
of triglycerides and overall energy homeostasis. As essen-
tial amino acid limitation in nature is almost always corre-
lated with other deprivation or starvation, we speculate
that GCN2 may act as a master regulator of metabolic
adaptation to nutrient deprivation.
EXPERIMENTAL PROCEDURES
Animals, Diets, and C75 Treatment
Wild-type C57BL/6J (Gcn2+/+) mice were obtained from The Jackson
Laboratory. Gcn2/ mice backcrossed onto the C57BL/6J back-
ground for eight generations were generated as previously described
(Zhang et al., 2002b). All mice used were in the C57BL/6J genetic
background. Two- to three-month-old male and female Gcn2+/+ and
Gcn2/ mice were maintained on a 12 hr light/dark cycle and were
provided free access to commercial rodent chow and tap water prior
to the experiments. Control (nutritionally complete amino acid) and
()leu (leucine-deficient) diets were obtained from Research Diets,
Inc. All diets were isocaloric and compositionally the same in terms
of carbohydrate and lipid component. At the start of the feeding exper-
iment, mice were acclimated to control diet for 10 days and then
randomly assigned to either control diet group, with continued free
access to the nutritionally complete diet, or ()leu diet group, with112 Cell Metabolism 5, 103–114, February 2007 ª2007 Elsevierfree access to the diet devoid of the essential amino acid leucine for
either 17 or 7 days. Treatment experiments with C75 (Calbiochem),
an inhibitor of Fas gene expression, were performed on Gcn2/
mice fed the leucine-deficient diet. In the C75-treated group, mice
were injected intraperitoneally (i.p.) with 20 mg/kg body weight C75
in 200 ml of RPMI on the 2nd, 4th, and 6th day on the leucine-deficient
diet; in the non-C75-treated control group, mice were injected i.p. with
200 ml of RPMI accordingly. The dose of C75was determined based on
a previous report showing that 24 hr after a single i.p. injection of C75 at
a dose of 30 mg/kg body weight, significant reduction of liver FAS
expression results (Kim et al., 2002). Food intake and body weight
were recorded daily. Animals were killed by CO2 inhalation, and trunk
blood was collected for the assays described below. Body, liver, and
adipose tissue weight were recorded at the time of sacrifice. Livers
were isolated and either put into 10% paraformaldehyde buffer imme-
diately for histological study (described later) or snap frozen and stored
at20C for future analysis. These experiments were approved by the
Pennsylvania State University Institutional Animal Care and Use
Committee.
Serum Measurements
Serum was obtained by centrifugation of clotted blood, snap frozen in
liquid nitrogen, and stored at 20C. Serum triglyceride, total choles-
terol, and free fatty-acid levels were determined enzymatically using
triglyceride reagent (Sigma), Infinity cholesterol reagent (Thermo),
and NEFA C reagent (Wako), respectively. Serum insulin was mea-
sured using the Mercodia Ultrasensitive Rat Insulin ELISA kit (ALPCO
Diagnostic). All assays were performed according to manufacturer’s
instructions.
Liver Lipid and Glycogen Assays
Lipids were extracted using chloroform/methanol (2:1, v/v) and evap-
orated in a heat block, and the pellets were dissolved in water as
previously described (Herzig et al., 2003). Liver triacylglycerol and total
cholesterol content were determined using the commercial reagents
or kits described above. Values were calculated as mg/g wet tissue.
Liver glycogen content was assayed using glucose assay reagent
(G3293, Sigma) and enzyme amyloglucosidase (Sigma) as previously
described (Passonneau and Lauderdale, 1974). Values were calcu-
lated as mmol/mg wet tissue.
Oil Red O and Hematoxylin and Eosin
Frozen sections of liver (5 mm) were stained with oil red O. Formalin-
fixed, paraffin-embedded sections (5 mm) of liver were stained with
hematoxylin and eosin for histology.
FAS Enzyme Activity Assay
FAS activity was performed as described previously (Kim et al., 1981)
with some modifications. The rate of NADPH oxidation was measured
at 340 nm before and after addition of the substrate malonyl-CoA. The
concentration of enzyme was adjusted to assure a linear reaction rate.
RNA Isolation and Relative Quantitative RT-PCR
Total RNAwas prepared from frozen liver using an RNasemini kit (QIA-
GEN). Quantitative RT-PCR was performed using coamplification of
GAPDH as an internal control. One microgram of RNA was reverse
transcribed with random primers (Promega), and quantitative PCR
was performed with a qPCR core kit for SYBR green I (Eurogentec)
by 7000 Sequence Detection System (Applied Biosystems). PCR
products were subjected to a melting curve analysis. At a specific
threshold in the linear amplification stage, the cycle differences be-
tween amplifiedGAPDH and cDNAs of interest were used to determine
the relative quantity of genes of interest. Primers used for real-time
PCR are listed in Table S1.
Western Blot Analysis
Nuclear extraction from frozen liver was performed as previously
described (Tai et al., 2000). Whole-cell lysates from frozen liver wereInc.
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GCN2 Regulates Lipid Metabolismisolated using Tris-based lysis buffer. Protease inhibitor and phospha-
tase inhibitors were added to all buffers before experiments. Western
blot was performed as previously described (Zhang et al., 2002a) using
30 mg of protein for each sample. Protein concentration was assayed
using Bio-Rad reagent. Primary antibodies (anti-FAS antibody [BD
Scientific], anti-PPARg antibody [Upstate], and anti-SREBP-1c anti-
body [Santa Cruz Biotechnology]) were incubated overnight at 4C
followed by ECL Plus (Amersham/Pharmacia) visualization of specific
proteins. Band intensities were measured using ImageQuant (Molecu-
lar Dynamics/Amersham/Pharmacia). Intensity valueswere normalized
to a-tubulin or nonspecific protein on the membrane.
Data Analysis
All data are expressed as mean ± SEM for experiments including
numbers of mice as indicated. The two-tailed Student’s t test was
used to evaluate statistical differences between control diet group
and ()leu diet group with or without C75 treatment within the same
strains of mice. There was no significant effect on parameters shown
between mice of different strains when fed a control diet. Means for
all parameters examined in current study were calculated indepen-
dently for male and female mice. No statistical difference in the re-
sponse of male and female mice to leucine deprivation was observed
(two-tailed Student’s t test, p > 0.05).
Supplemental Data
Supplemental Data include three figures and one table and can be
found with this article online at http://www.cellmetabolism.org/cgi/
content/full/5/2/103/DC1/.
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